Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

Clinical trial NCT03760198 · COMPLETED

Trial details

NCT number: NCT03760198
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperhidrosis Primary Focal Axilla

Start date: 2018-08-03
Primary completion: 2019-07-03
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.